Tags : JW Pharmaceutical


Simcere Signs an Exclusive License Agreement with JW Pharmaceutical for

Shots: JWP to receive up front, commercial milestones & royalties on sales in China.  Simcere to get the license for clinical research, registration, and commercialization of URC-102 in China (including Hongkong & Macao) The collaboration will combine JWP’s expertise in new molecular entity drug discovery & development with Simcere expertise in clinical development and commercialization […]Read More